← Back to Search

Problem List Suggestion for Asthma (IQ-MAPLE Trial)

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All providers over the age of 18 that use the electronic health record at the specific site that the intervention is being observed.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, or up to 1 year
Awards & highlights

IQ-MAPLE Trial Summary

This trial is designed to improve care for patients with heart, lung and blood conditions by facilitating more accurate and complete problem list documentation.

Eligible Conditions
  • Asthma
  • High Cholesterol
  • Atrial Fibrillation
  • Chronic Obstructive Pulmonary Disease
  • Coronary Artery Disease
  • Congestive Heart Failure
  • Heart Attack
  • Sickle Cell Disease
  • Sleep Apnea
  • Smoking
  • Stroke
  • Tuberculosis
  • High Blood Pressure

IQ-MAPLE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

IQ-MAPLE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, or up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, or up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determining the effect of problem list completion by comparing the number of study-related problems added to problem lists in the electronic health record
Determining the quality of care impact of adding suggested problems to the problem list based on 4 outcome measures from NCQA's HEDIS 2013 measure set
Measuring the rate of acceptance of alerts calculated by number of acceptances for each alert divided by the total number of unique presentations of the alert
Secondary outcome measures
Evaluating process measures using key process measures for each study condition from CMS, NHLBI, and NQMC

IQ-MAPLE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Sites will configure their EHR systems so that alerts for these conditions will be triggered for providers in the intervention arm if the patient does not have the condition on her/his problem list. Each alert will be actionable and allow the provider to add the problem to her or his patient's problem list with a single click. The provider will also be able to override the rule of the patient does not have the condition (in which case the alert will not be displayed again unless new information that would trigger the alert is added to the patient's record), or defer the alert until later.
Group II: Normal Use of EHRActive Control1 Intervention
Sites will configure their EHR systems so that alerts will not be triggered for providers in the control arm if the patient does not have the condition on her/his problem list.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,608 Previous Clinical Trials
11,467,491 Total Patients Enrolled
41 Trials studying Asthma
213,590 Patients Enrolled for Asthma
Geisinger ClinicOTHER
148 Previous Clinical Trials
1,883,707 Total Patients Enrolled
1 Trials studying Asthma
15 Patients Enrolled for Asthma
Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
6,843,643 Total Patients Enrolled
3 Trials studying Asthma
885 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this exploration currently admitting participants?

"Unfortunately, according to the information provided by clinicaltrials.gov this particular medical trial is not actively recruiting at this time. First posted on April 1st 2016 and last updated December 5th 2016, it remains closed for enrollment despite 4677 other studies accepting new patients right now."

Answered by AI

How many facilities are managing this research endeavor?

"This clinical trial is being carried out in four different medical centres, including Brigham and Women's Hospital in Boston, Vanderbilt University Medical Center in Nashville, Holy Spirit Hospital in Camp Hill, as well as one other site."

Answered by AI
Recent research and studies
~265 spots leftby Apr 2025